NCT04699162View on ClinicalTrials.gov

Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

October 31, 2020

Study Completion Date

December 31, 2020

Conditions

Acute Lymphoblastic Leukemia

Trial Locations (2)

56530

Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca

06720

"Hospital General de México Dr. Eduardo Liceaga", Mexico City

All Listed Sponsors

lead

Christian Omar Ramos-Peñafiel, MD, PhD

OTHER_GOV

NCT04699162 - Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter